Stelara 90 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FCFB3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,598
Award facts
- Contract value 100% obligated
- $20,598.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,598.16 to DMS Pharmaceutical Group Inc. on January 6, 2026, for the supply of Stelara 90 mg/mL syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected through firm fixed-price pricing with no set-aside designation. The delivery order carries an ultimate completion date of January 28, 2026, and will be performed at the awardee's location in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion acquisition strategy. The parent IDC, awarded on November 13, 2025, with a $499.9 billion ceiling value and completion date of December 31, 2036, authorizes DLA to issue delivery orders for a comprehensive range of pharmaceuticals, biologics, and medical consumables to support Department of Defense healthcare operations globally. DMS Pharmaceutical Group has demonstrated substantial capability in federal pharmaceutical procurement, with delivery orders historically ranging from under $100 to over $115,000 across oncology treatments, immunosuppressants, vaccines, and specialty pharmaceuticals.
Quick answers
Who was awarded contract SPE2DR26FCFB3?
SPE2DR26FCFB3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FCFB3 worth?
The government has obligated $20,598 on SPE2DR26FCFB3.
Is contract SPE2DR26FCFB3 an order under another contract?
Yes. SPE2DR26FCFB3 is a delivery order under SPE2DR25D9130, an indefinite delivery contract.
Was contract SPE2DR26FCFB3 competed?
The extent of competition for SPE2DR26FCFB3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award